7-Chloro-4-aminoquinoline γ-hydroxy-γ-lactam derived-tetramates as a new family of antimalarial compounds. |
|
Analyse anthropobiologique de la susceptibilité au paludisme chez l'homme |
|
Anthropobiological analysis of malaria susceptibility in humans. |
|
Antimalarial stewardship programs are urgently needed for malaria elimination: a perspective |
|
Apoptosis induced by parasitic diseases |
|
Are protozoan metacaspases potential parasite killers? |
|
Artesunate-erythropoietin combination for murine cerebral malaria treatment. |
|
Automated Plasmodium detection by the Sysmex XN hematology analyzer. |
|
Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade |
|
Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta-analysis |
|
Contribution à l'étude des effets biologiques d'un perturbateur endocrinien : le bisphénol A |
|
Cryptic Plasmodium ovale concurrent with mixed Plasmodium falciparum and Plasmodium malariae infection in two children from Central African Republic |
|
Dermatophytes and transmission risks to family: a retrospective study of a cohort of 256 adopted children from 1998 to 2012. |
|
Development of a radioimmunoassay for the measurement of Bisphenol A in biological samples. |
|
Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for screening patients with imported malaria in a non-endemic setting. |
|
Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing Plasmodium parasites based on enzyme activity measurement |
|
Efficacy of intranasal administration of artesunate in experimental cerebral malaria |
|
Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice |
|
Etude biochimique et sélection d'inhibiteurs spécifiques d'une cible thérapeutique leishmanienne : la GDP-Mannose-Pyrophosphorylase |
|
Etude des propriétés cytoprotectrices de l'éryhtropoïétine dans des modèles d'infection aspergillaire in vitro sur cellules endothéliales humaines et in vivo sur souris |
|
Evaluation de la prescription des antifongiques dans le traitement curatif des aspergilloses et candidoses profondes |
|
Evaluation of ferrocenyl-containing γ-hydroxy-γ-lactam-derived tetramates as potential antiplasmodials |
|
Evaluation of the malaria rapid diagnostic test VIKIA malaria Ag Pf/Pan™ in endemic and non-endemic settings |
|
Fungaemia caused by Fusarium proliferatum in a patient without definite immunodeficiency. |
|
Genetic diversity of Plasmodium vivax metacaspase 1 and Plasmodium vivax multi-drug resistance 1 genes of field isolates from Mauritania, Sudan and Oman. |
|
Impact of a change in protected environment on the occurrence of severe bacterial and fungal infections in children undergoing hematopoietic stem cell transplantation |
|
Improvement in the Outcome of Invasive Aspergillosis in a Pediatric Hematology Department: A 10-Year Review. |
|
Incorporation of a 3-(2,2,2-trifluoroethyl)-γ-hydroxy-γ-lactam motif in the side chain of 4-aminoquinolines. Syntheses and antimalarial activities |
|
Interaction between environment, nutrient-derived metabolites and immunity: A possible role in malaria susceptibility/resistance in Fulani and Dogon of Mali |
|
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. |
|
Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. |
|
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole. |
|
Métacaspases : cibles thérapeutiques contre le paludisme |
|
Metacaspases : New Targets for Malaria Treatment. |
|
Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population |
|
Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers |
|
Neuroprotection and Cerebral Malaria, Of Mice and Men. |
|
Neuroprotection et neuropaludisme des souris et des hommes |
|
New anti-malarial drugs: who cares? |
|
No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients-think empirical treatment |
|
An outbreak of locally acquired Plasmodium vivax malaria among migrant workers in Oman |
|
Place des hémocultures fongiques dans la stratégie diagnostique des candidoses invasives |
|
Plasmodium vivax infection: not so benign |
|
Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients |
|
Primary cutaneous cryptococcosis in a liver transplant recipient. |
|
Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study. |
|
Revue systématique de la pharmacocinétique de l'artésunate : implication dans le traitement du paludisme résistant |
|
Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole |
|
Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali |
|
Sodium valproate and dysmegakaryocytopoiesis |
|
Statins alone are ineffective in cerebral malaria but potentiate artesunate |
|
Synthèse et évaluation d'assemblages moléculaires programmés dédiés au traitement des infections fongiques invasives |
|
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria |
|
Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana |
|
Wanted Plasmodium falciparum, dead or alive |
|